Audrey Didelot

2.1k total citations
33 papers, 1.3k citations indexed

About

Audrey Didelot is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Audrey Didelot has authored 33 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cancer Research, 14 papers in Molecular Biology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Audrey Didelot's work include Cancer Genomics and Diagnostics (19 papers), Genetic factors in colorectal cancer (8 papers) and Molecular Biology Techniques and Applications (4 papers). Audrey Didelot is often cited by papers focused on Cancer Genomics and Diagnostics (19 papers), Genetic factors in colorectal cancer (8 papers) and Molecular Biology Techniques and Applications (4 papers). Audrey Didelot collaborates with scholars based in France, United States and Switzerland. Audrey Didelot's co-authors include Pierre Laurent‐Puig, Hélène Blons, Valérie Taly, Nicolas Pécuchet, Fanny Garlan, Elizabeth Fabre, Karine Pallier, Laure Gibault, Aziz Zaanan and Daniel Pietrasz and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Audrey Didelot

32 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Audrey Didelot France	17	762	626	516	485	319	33	1.3k
Karine Pallier France	10	427 0.6×	337 0.5×	308 0.6×	425 0.9×	197 0.6×	11	880
Neal Lindeman United States	7	644 0.8×	339 0.5×	372 0.7×	296 0.6×	216 0.7×	10	920
Alexey Aleshin United States	21	828 1.1×	863 1.4×	583 1.1×	491 1.0×	341 1.1×	90	1.6k
Chit Chow Hong Kong	21	396 0.5×	646 1.0×	568 1.1×	534 1.1×	184 0.6×	53	1.4k
Tomo Osako Japan	19	646 0.8×	440 0.7×	168 0.3×	335 0.7×	345 1.1×	48	1.1k
Sarah Derks Netherlands	19	298 0.4×	766 1.2×	517 1.0×	651 1.3×	304 1.0×	54	1.6k
Marina Baretti United States	13	333 0.4×	531 0.8×	293 0.6×	367 0.8×	211 0.7×	50	969
Penny Flohr United Kingdom	15	543 0.7×	390 0.6×	787 1.5×	621 1.3×	92 0.3×	27	1.3k
Stacy L. Mach United States	7	1.0k 1.4×	664 1.1×	1.1k 2.1×	456 0.9×	233 0.7×	13	1.5k
Allison O’Connell United States	6	1.1k 1.4×	659 1.1×	933 1.8×	448 0.9×	218 0.7×	9	1.4k

Countries citing papers authored by Audrey Didelot

Since Specialization

Citations

This map shows the geographic impact of Audrey Didelot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Audrey Didelot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Audrey Didelot more than expected).

Fields of papers citing papers by Audrey Didelot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Audrey Didelot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Audrey Didelot. The network helps show where Audrey Didelot may publish in the future.

Co-authorship network of co-authors of Audrey Didelot

This figure shows the co-authorship network connecting the top 25 collaborators of Audrey Didelot. A scholar is included among the top collaborators of Audrey Didelot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Audrey Didelot. Audrey Didelot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zaanan, Aziz, Audrey Didelot, Chloé Broudin, et al.. (2025). Longitudinal circulating tumor DNA analysis during treatment of locally advanced resectable gastric or gastroesophageal junction adenocarcinoma: the PLAGAST prospective biomarker study. Nature Communications. 16(1). 6815–6815. 1 indexed citations

Borghese, Bruno, Jérôme Alexandre, Simon Garinet, et al.. (2025). Identification of a very-high risk subgroup of localized endometrial carcinoma before surgery using circulating tumor DNA: a proof-of-concept study. International Journal of Gynecological Cancer. 35(10). 101941–101941.

Didelot, Audrey, Chloé Broudin, George Laliotis, et al.. (2024). Longitudinal circulating tumor DNA (ctDNA) analysis during treatment (Tx) of locally advanced resectable (LAR) gastric or gastroesophageal junction (G/GEJ) adenocarcinoma (ADENOCA): The PLAGAST prospective biomarker study.. Journal of Clinical Oncology. 42(16_suppl). 4028–4028. 2 indexed citations

Didelot, Audrey, Simon Garinet, Aurélien de Reyniès, et al.. (2024). PrPC controls epithelial-to-mesenchymal transition in EGFR-mutated NSCLC: implications for TKI resistance and patient follow-up. Oncogene. 43(37). 2781–2794. 3 indexed citations

Garinet, Simon, Audrey Didelot, Laëtitia Marisa, et al.. (2023). A novel Chr1-miR-200 driven whole transcriptome signature shapes tumor immune microenvironment and predicts relapse in early-stage lung adenocarcinoma. Journal of Translational Medicine. 21(1). 324–324. 1 indexed citations

Taly, Valérie, Simon Garinet, Audrey Didelot, et al.. (2021). Role of Circulating Tumor DNA in Gastrointestinal Cancers: Current Knowledge and Perspectives. Cancers. 13(19). 4743–4743. 15 indexed citations

Garinet, Simon, Audrey Didelot, Thomas Denize, et al.. (2021). Clinical assessment of the miR-34, miR-200, ZEB1 and SNAIL EMT regulation hub underlines the differential prognostic value of EMT miRs to drive mesenchymal transition and prognosis in resected NSCLC. British Journal of Cancer. 125(11). 1544–1551. 20 indexed citations

Ghazi, Alexandre, Delphine Le Corre, Camilla Pilati, et al.. (2021). Prognostic value of the PrP ^C -ILK-IDO1 axis in the mesenchymal colorectal cancer subtype. OncoImmunology. 10(1). 1940674–1940674. 12 indexed citations

Legras, Antoine, Audrey Didelot, Corinne Normand, et al.. (2020). High expression of spliced X-Box Binding Protein 1 in lung tumors is associated with cancer aggressiveness and epithelial-to-mesenchymal transition. Scientific Reports. 10(1). 10188–10188. 14 indexed citations

10.

Bancaud, Aurélien, Audrey Didelot, Fréderic Fina, et al.. (2018). BIABooster: Online DNA Concentration and Size Profiling with a Limit of Detection of 10 fg/μL and Application to High-Sensitivity Characterization of Circulating Cell-Free DNA. Analytical Chemistry. 90(6). 3766–3774. 31 indexed citations

11.

Legras, Antoine, Anne Tallet, Audrey Didelot, et al.. (2018). Clinical and molecular characteristics of unicentric mediastinal Castleman disease. Journal of Thoracic Disease. 10(4). 2079–2088. 5 indexed citations

12.

Garlan, Fanny, Pierre Laurent‐Puig, David Sefrioui, et al.. (2017). Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study). Clinical Cancer Research. 23(18). 5416–5425. 165 indexed citations

13.

Pietrasz, Daniel, Nicolas Pécuchet, Fanny Garlan, et al.. (2016). Plasma Circulating Tumor DNA in Pancreatic Cancer Patients Is a Prognostic Marker. Clinical Cancer Research. 23(1). 116–123. 183 indexed citations

14.

Pécuchet, Nicolas, Eleonora Zonta, Audrey Didelot, et al.. (2016). Base-Position Error Rate Analysis of Next-Generation Sequencing Applied to Circulating Tumor DNA in Non-Small Cell Lung Cancer: A Prospective Study. PLoS Medicine. 13(12). e1002199–e1002199. 75 indexed citations

15.

Zonta, Eleonora, Fanny Garlan, Nicolas Pécuchet, et al.. (2016). Multiplex Detection of Rare Mutations by Picoliter Droplet Based Digital PCR: Sensitivity and Specificity Considerations. PLoS ONE. 11(7). e0159094–e0159094. 82 indexed citations

16.

Mansuet‐Lupo, Audrey, Antonio Bobbio, Hélène Blons, et al.. (2014). The New Histologic Classification of Lung Primary Adenocarcinoma Subtypes Is a Reliable Prognostic Marker and Identifies Tumors With Different Mutation Status. CHEST Journal. 146(3). 633–643. 76 indexed citations

17.

Laforest, A., Thomas Aparicio, Aziz Zaanan, et al.. (2014). ERBB2 gene as a potential therapeutic target in small bowel adenocarcinoma. European Journal of Cancer. 50(10). 1740–1746. 72 indexed citations

18.

Manceau, Gilles, Éric Letouzé, Cécile Guichard, et al.. (2012). Recurrent inactivating mutations of ARID2 in non‐small cell lung carcinoma. International Journal of Cancer. 132(9). 2217–2221. 58 indexed citations

19.

Didelot, Audrey, Delphine Le Corre, Armelle Luscan, et al.. (2012). Competitive allele specific TaqMan PCR for KRAS, BRAF and EGFR mutation detection in clinical formalin fixed paraffin embedded samples. Experimental and Molecular Pathology. 92(3). 275–280. 91 indexed citations

20.

Guilloton, L., et al.. (2008). Syndrome de céphalées et déficits neurologiques transitoires avec lymphocytose du liquide céphalorachidien. La Revue de Médecine Interne. 29(5). 397–400. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact